Previous close | 0.2000 |
Open | 0.4000 |
Bid | 0.0000 |
Ask | 0.5500 |
Strike | 7.50 |
Expiry date | 2024-05-17 |
Day's range | 0.4000 - 0.4500 |
Contract range | N/A |
Volume | |
Open interest | 20 |
Relay Therapeutics ( NASDAQ:RLAY ) First Quarter 2024 Results Key Financial Results Revenue: US$10.0m (up by US$9.78m...
Despite Net Loss, Relay Therapeutics Reports Significant Revenue Growth and Robust Pipeline Progress
Relay Therapeutics (RLAY) delivered earnings and revenue surprises of 11.43% and 2,905.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?